Indrayani Biotech Ltd clarified that their consolidated financial results for the quarter ended December 31, 2024, did not include the financials of their material subsidiary, DFPL, as the necessary data was not received, which led to the adjournment of the board meeting originally scheduled for February 14, 2025.